McGowan Group Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,916
| Closed | -$201K | – | 131 |
|
|
2023
Q4 | $201K | Sell |
3,916
-164
| -4% | -$8.61K | 0.03% | 129 |
|
|
2023
Q3 | $237K | Sell |
4,080
-238,118
| -98% | -$14.6M | 0.04% | 120 |
|
|
2023
Q2 | $15.5M | Buy |
242,198
+726
| +0.3% | +$48.7K | 2.41% | 13 |
|
|
2023
Q1 | $16.7M | Sell |
241,472
-2,051
| -0.8% | -$145K | 2.66% | 13 |
|
|
2022
Q4 | $17.5M | Buy |
243,523
+3,532
| +1% | +$266K | 2.79% | 13 |
|
|
2022
Q3 | $17.1M | Buy |
239,991
+1,388
| +0.6% | +$101K | 2.96% | 11 |
|
|
2022
Q2 | $18.4M | Buy |
238,603
+44,686
| +23% | +$3.4M | 3.08% | 10 |
|
|
2022
Q1 | $14.2M | Buy |
193,917
+802
| +0.4% | +$53.9K | 2.18% | 11 |
|
|
2021
Q4 | $12M | Buy |
193,115
+162
| +0.1% | +$9.5K | 2.12% | 16 |
|
|
2021
Q3 | $11.4M | Buy |
192,953
+3,157
| +2% | +$208K | 1.94% | 17 |
|
|
2021
Q2 | $12.7M | Buy |
189,796
+1,277
| +0.7% | +$83.3K | 1.99% | 15 |
|
|
2021
Q1 | $11.9M | Buy |
188,519
+4,611
| +3% | +$287K | 1.94% | 18 |
|
|
2020
Q4 | $11.4M | Buy |
183,908
+6,561
| +4% | +$403K | 1.95% | 17 |
|
|
2020
Q3 | $10.7M | Buy |
177,347
+10,973
| +7% | +$660K | 2.03% | 14 |
|
|
2020
Q2 | $9.78M | Sell |
166,374
-4,123
| -2% | -$247K | 1.82% | 17 |
|
|
2020
Q1 | $9.5M | Buy |
+170,497
| New | +$10.4M | 2.08% | 14 |
|
|
2018
Q4 | – | Sell |
-3,622
| Closed | -$225K | – | 95 |
|
|
2018
Q3 | $225K | Hold |
3,622
| – | – | 0.04% | 100 |
|
|
2018
Q2 | $200K | Hold |
3,622
| – | – | 0.03% | 106 |
|
|
2018
Q1 | $229K | Hold |
3,622
| – | – | 0.04% | 94 |
|
|
2017
Q4 | $222K | Hold |
3,622
| – | – | 0.04% | 98 |
|
|
2017
Q3 | $231K | Hold |
3,622
| – | – | 0.05% | 80 |
|
|
2017
Q2 | $202K | Buy |
+3,622
| New | +$197K | 0.04% | 78 |
|
|
2017
Q1 | – | Sell |
-3,622
| Closed | -$212K | – | 84 |
|
|
2016
Q4 | $212K | Buy |
+3,622
| New | +$198K | 0.04% | 84 |
|
|
2016
Q3 | – | Sell |
-3,622
| Closed | -$266K | – | 92 |
|
|
2016
Q2 | $266K | Hold |
3,622
| – | – | 0.05% | 99 |
|
|
2016
Q1 | $231K | Buy |
3,622
+218
| +6% | +$13.7K | 0.04% | 112 |
|
|
2015
Q4 | $234K | Hold |
3,404
| – | – | 0.05% | 123 |
|
|
2015
Q3 | $202K | Buy |
3,404
+130
| +4% | +$8.25K | 0.04% | 133 |
|
|
2015
Q2 | $218K | Hold |
3,274
| – | – | 0.04% | 126 |
|
|
2015
Q1 | $211K | Buy |
+3,274
| New | +$205K | 0.04% | 122 |
|
Other funds holding BMY
McGowan Group Asset Management's BMY Position: Q1 2024 in Review
McGowan Group Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 3,916 shares — an estimated $201K sold.
McGowan Group Asset Management first reported a position in BMY in Q1 2015 and held it in 29 quarters. The position peaked at $18.4M in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- McGowan Group Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- McGowan Group Asset Management sold 3,916 Bristol-Myers Squibb shares in Q1 2024, an estimated $201K.
- McGowan Group Asset Management first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 29 quarters.
- McGowan Group Asset Management's Bristol-Myers Squibb position peaked at $18.4M in Q2 2022.
- 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on McGowan Group Asset Management's 13F filing for Q1 2024, filed 15 May 2024.